Modern ICDs have built-in protection from interference by most current technologies. But do you know which ones could be problematic for your patients?
GLP-1RAs, SGLT2is Cut Risk of Future MI, Stroke in Survivors: Daily Dose
Your daily dose of the clinical news you may have missed.
Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care
Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.
COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types
Prior SARS-CoV-2 infection was associated with a 2-fold increased risk for MACE for up to 3 years, even among people with no history of CVD, in a new analysis of UK Biobank data.
Primary Viewpoints Episode 4: Lp(a): The Next CVD Target?
Patrick Moriarty, MD, from the University of Kansas Medical Center, discusses the role of Lp(a) as a risk factor for cardiovascular disease and the phase 3 trials of a potential treatment.
Recent Recreational Drug Use Ups Risk of Repeat Serious CV Event: Daily Dose
Statin Plus Ezetimibe Outperforms High-Dose Statins in LDL-C Reduction: Daily Dose